Pyomyositis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Pyomyositis.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Pyomyositis.
Check the disease page for updates →

Approved Treatments

2 FDA-approved

Dyural 80-Lm

(METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL)Orphan drugstandard

Advanced Rx Pharmacy of Tennessee, LLC

12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical...

FDA label ↗

Ocuflox Ophthalmic Solution

(Ofloxacin)Orphan drugstandard

Allergan, Inc.

Quinolone Antimicrobial [EPC]

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Pyomyositis.
Search all trials →
Search clinical trials for Pyomyositis

Recent News & Research

1 article
ClinicalTrials.govJan 28, 2026

New recruiting trial: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research prior...

Read ↗

Browse all Pyomyositis news →

Specialist Network

Top 2 by expertise

View all Pyomyositis specialists →

Quick Actions